Some of our services have changed due to COVID-19. Click here for details

Dr Nick Kelland

  • Consultant Cardiologist and Electrophysiologist


General Cardiology
Complex device implantation

Professional Profile

After graduating from Oxford, Dr Kelland completed General Medical Training in Newcastle, before gaining a British Heart Foundation funded PhD in Endothelial Function,  from the University of Edinburgh. He returned to the North East to train in Cardiology, sub-specialising in Electrophysiology and Devices whilst working at the Freeman, Newcastle and James Cook University (Middlesbrough) Hospitals. This was complemented by a Fellowship in the Royal Melbourne Hospital, Australia, working with Professor Jonathan Kalman. He took up his Consultant post in Cardiac Electrophysiology and Devices at the Northern General Hospital, Sheffield Teaching Hospitals Foundation NHS Trust  in 2012. He now performs over 250 Electrophysiological and Device procedures each year, dealing with all types of arrhythmia, included VT and AF, using the latest ablation techniques.

Current membership(s) of professional, national and regional bodies and university posts

Honorary Senior Lectureship, Sheffield University
Member Royal College of Physicians of Edinburgh
Member of British Heart Rhythm Society
Member of Hospital Consultants and Specialists Association


PhD Thesis

  1. Kelland NF. (2007) Investigation of the role of the endothelial cell Endothelin B receptor in cardiovascular function. University of Edinburgh.

 Original papers

  1. Bagnall AB and Kelland NF, Gulliver-Sloan FH, Davenport AP, Gray GA, Yanagisawa M, Webb DJ and Kotelevtsev YV. (2006). Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension: 48; 286-93.
  2. Kelland NF, Bagnall AJ, Morecroft I, Gulliver-Sloan FH, Dempsie Y, Nilsen M, Yanagisawa M, Maclean MR, Kotelevtsev YV, Webb DJ. Endothelial ET(B) Limits Vascular Remodelling and Development of Pulmonary Hypertension during Hypoxia. J Vasc Res. 2009; 47:16-22.
  3. Kelland NF, Kuc RE, Armour DL, Bagnall AJ, Gulliver-Sloan F, Maguire JJ, Davenport AP, Gray GA, Kotelevtsev Y and Webb DJ. Endothelial Cell Specific Knockout of the Endothelin B Receptor Demonstrates Its Crucial Role In The Clearance Of Endothelin-1. Can J Physiol Pharm 88: 644-651.
  4. Kumar S, Haqqani HM, Chan M, Lee J, Yudi M, Wong MC, Morton JB, Ling LH, Robinson T, Heck PM,Kelland NF, Halloran K, Spence SJ, Kistler PM, Kalman JM. (2013). Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm: 10(7):962-9.
  5. Kumar S, Sutherland F, Lee JM, Robinson T, Heck PM, Wong MC, Kelland NF, Garg ML, Sparks PB. (2013) Effects of high dose intravenous fish oil on human atrial electrophysiology: implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation. Int J Cardiol. 3;168(3):2754-60
  6. Nelson T, Bhaktia A, Lee J, Sahu, J, Sheridan P, Bowes R and Kelland NF. Evaluation of a new same day discharge protocol for simple and complex pacing procedures. Europace (submitted).

 Reviews/ Editorials/Letters/Case reports

  1. Kelland NF, Webb, DJ. Book Review: ACE Inhibitors. British Journal of Clinical Pharmacology 2002;54:337-8.
  2. Kelland NF. Symposium Report: Expedition Medicine. J R Coll Physicians Edinburgh 2005. 35:353-5.
  3. Kelland NF, Webb, DJ. (2006). Clinical Trials of Endothelin Antagonists in Heart Failure: A Question of Dose? Experimental Biology and Medicine: 231; 696-699
  4. Battistini B, Berthiaume N, Kelland NF, Webb DJ and Kohan DE. (2006). Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel "-Sentan" Class of Drug. Experimental Biology and Medicine: 231; 653-695.
  5. Kelland NF and Webb DJ. (2007). Clinical trials of endothelin antagonists in heart failure: publication is good for the public health. Heart: 93; 2-4.
  6. Kelland NF, Roberts AP. Letter by Kelland and Roberts regarding article, "Lipid management to reduce cardiovascular risk: a new strategy is required". Circulation. 2008;118:e119.
  7. Leong KM, Kelland NF. (2013). Pre-excitation on the electrocardiogram: what next? Br J Hosp Med (Lond). 2013 Nov;74(11):636-40.
  8. Fent GJ, Kamaruddin H, Garg P, Iqbal A, Kelland NF and Hall IR. Hypertensive Emergency and Type 2 Myocardial Infarction Resulting From Pheochromocytoma and Concurrent Capnocytophaga Canimorsus Infection. Open Cardiovasc Med J. 2014 Jun 13;8:43-7
  9. Parker WAE, Sahu J, Lee JMS, Wheeldon NM, Al-Mohammed A, Cooke CJ, Wechalekar AD, Chantry A, Kelland NF. An Unusual Cause of Refractory Polymorphic Ventricular Tachycardia. European Heart J (submitted).


Additional Information

Secretary contact details

Name: Mrs Paula Hamilton
Telephone: 0114 2715379



< back

Rate this page: